What is Okra Technologies?
Founded in 2015 and headquartered in Cambridge, UK, Okra Technologies operates at the intersection of artificial intelligence and life sciences. The company is best known for its proprietary OKRA Engine, a sophisticated platform that integrates machine learning with a hybrid explainability framework. This architecture allows stakeholders in the medical and commercial sectors to move beyond simple data visualization, providing real-time, evidence-based predictions and suggestions. By offering transparent reasoning behind its AI-generated outputs, Okra Technologies addresses the critical need for trust and interpretability in high-stakes healthcare decision-making, effectively optimizing market access and medical outcomes for global life science enterprises.
How much funding has Okra Technologies raised?
Okra Technologies has raised a total of $2.1M across 1 funding round:
Series A
$2.1M
Series A (2018): $2.1M, investors not publicly disclosed
Key Investors in Okra Technologies
Undisclosed Investor
An undisclosed investor participating in the funding round, providing essential capital to support the scaling of AI-driven life science solutions.
What's next for Okra Technologies?
With this major strategic investment, Okra Technologies is well-positioned to scale its operations and deepen its footprint in the European and global life sciences markets. The company is expected to focus on enhancing the predictive capabilities of its engine, potentially expanding its reach into new therapeutic areas and regulatory environments. As the industry shifts toward data-centric commercialization, Okra's focus on explainable AI will likely serve as a competitive moat, enabling the firm to capture a larger share of the enterprise-level healthcare analytics market. Future growth will likely be defined by strategic partnerships with pharmaceutical giants seeking to integrate evidence-based intelligence into their core operational strategies.
See full Okra Technologies company page
